Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect trial.

Michael G. Fehlings, Jefferson R. Wilson, Spyridon K. Karadimas, Paul M. Arnold, Branko Kopjar

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Clinical evaluation of a neuroprotective drug in patients with cervical spondylotic myelopathy undergoing surgical treatment: design and rationale for the CSM-Protect trial.'. Together they form a unique fingerprint.

Medicine & Life Sciences